Stay updated on ARO-HIF2 in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the ARO-HIF2 in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the ARO-HIF2 in Renal Cell Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4 on the page, indicating a minor maintenance update to the site's versioning. This change does not modify study content or how users interact with the page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, indicating a new version of the page was published. This update does not modify study data, eligibility criteria, or other substantive content.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows revision v3.6.2, replacing v3.6.0. This indicates a deployment update to the page without altering the study details or layout.SummaryDifference0.1%

- Check55 days agoChange DetectedThe enrollment status now indicates no longer recruiting participants, signaling that recruitment is complete. The page also adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and displays a Revision: v3.6.0, reflecting a UI/content update.SummaryDifference0.5%

- Check62 days agoChange DetectedThe revision label on the page was updated from v3.5.4 to v3.5.5, indicating a newer build of the page. This change reflects a maintenance update and does not modify the study data or core content.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page revision updated the version from v3.5.3 to v3.5.4, indicating a small update to the ClinicalTrials.gov entry, with no change to the listed study details or eligibility criteria.SummaryDifference0.1%

Stay in the know with updates to ARO-HIF2 in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-HIF2 in Renal Cell Carcinoma Clinical Trial page.